Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled Study

Füllert, S.; Schneider, Frank; Haak, Eva; Rau, Harald; Badenhoop, Klaus; Lübben, G; Usadel, K.-H.; R. Konrad, Thomas

doi:10.1210/jc.2002-020963

Public

Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled Study

Published in The Journal of Clinical Endocrinology & Metabolism • Dec 1, 2002

Authors:

S. Füllert

Frank Schneider

Eva Haak

Abstract

Hypertension is often associated with insulin resistance, dyslipidemia and obesity, which indicate a prediabetic state and increased risk of cardiovascular disease. Pioglitazone treatment of patients with type 2 diabetes reduces insulin resistance and improves lipid profiles. The present double-blin...

Subject

Pioglitazone

Internal medicine

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!